Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency
Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency is a research paper published in European Respiratory Journal (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
N/A
Scored on demand from live citation data
Open Access9 citations
Cite:
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
›Methodology & internals
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending
FAIR Checklist
Context only (not used in score)Findable (1/2)
- Has DOI
Accessible (1/2)
- Open Access
Interoperable (0/2)
Reusable (0/3)
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Run a calibrated FAIR evaluation for this paper →
We only score data papers we can read in full — never from an abstract alone.